Is NCT05204888 recruiting in Jacksonville, FL?

Yes, NCT05204888 is currently recruiting participants at its Jacksonville, FL location. This copd clinical trial is actively enrolling qualified participants.

How do I join the copd clinical trial in Jacksonville?

To join this clinical trial in Jacksonville, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Jacksonville clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

COPD Clinical Trial in Jacksonville, FL

About This COPD Study in Jacksonville

Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.

Sponsor: Temple University

Who Can Participate

Inclusion Criteria

• Current smokers must refrain from smoking when using supplemental oxygen or the myAirvo-3 device

History of a severe COPD exacerbation requiring hospitalization in the previous six weeks

COPD in a stable state after hospitalization defined as:

Clinically stable condition and have had no parenteral therapy for 24 hours.

Inhaled bronchodilators are required less than four-hourly.

Oxygen delivery has ceased for 24 hours (unless home oxygen is indicated).

If previously able, the patient is ambulating safely and independently, and performing activities of daily living.

The patient can eat and sleep without significant episodes of dyspnea.

The patient or caregiver understands and can administer medications.

Follow-up and home care arrangements (e.g., home oxygen, homecare, Meals on Wheels, community nurse, allied health, GP, specialist) have been completed.

Willing to adhere to the daily use of the myAirvo 3 regimen for at least 8 hours each day preferably at night following being shown and using the device

Willing to record daily symptoms and pulse oximetry and heart rate on daily basis

For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation Highly effective contraception is defined as:

A tubal ligation:

An approved hormonal contraceptive such as oral contraceptives, emergency contraception used as directed, patches, implants, injections, rings or intrauterine devices

Able to read and communicate in English

Have a home environment suitable for myAirvo 3 use.

Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration - refraining from smoking while receiving supplemental oxygen or the myAirvo-3 device

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

Current self-reported chronic use of positive airway pressure (PAP) therapy; continuous positive airway pressure (CPAP), or non-invasive positive pressure ventilation (NPPV)

A STOPBang Questionnaire score \> 5\

Pregnancy or lactation

Treatment with another investigational drug or other intervention within the previous 30 days

Life expectancy less than 12 months due to COPD or other comorbid condition.

Recent upper airway surgery (within the previous month)

Recent head or neck trauma (within the previous month)

Inability to tolerate nasal prongs

Requirement of oxygen greater than 15 L/min

subjects with a STOPBang questionnaire score of \> 5 may be eligible if a recent sleep study (within the previous 3 months) shows the absence of obstructive sleep apnea or the subject has, or is at risk of OSA, but refuses to use an OSA device and all other eligibility criteria are met.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Jacksonville?

Yes, this clinical trial (NCT05204888) has an active research site in Jacksonville, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

COPD Treatment Options in Jacksonville, FL

If you're searching for copd treatment options in Jacksonville, FL, this clinical trial (NCT05204888) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Jacksonville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all copd clinical trials near you to find additional studies recruiting in your area.

COPD Clinical Trial in Jacksonville, FL

Expert Care in Jacksonville

IRB Approved

No-Cost Care

Apply for This Jacksonville Location

Why Participate?

Simple Process